Skip to main content

Table 2 Comparison of circulating ANGPTL8 and apoCIII concentrations in CAD group and nonCAD group

From: Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism

 

All (n = 120)

CAD (n = 68)

Non-CAD (n = 52)

P value

ANGPTL8 (pg/ml)

561.1 (390.1–882.9)

544.4 (374.3–903.7)

597.7 (408.6–853.1)

NS

ApoCIII (mg/dl)

11.7 (9.1–13.5)

10.6 (8.8–12.3)

11.3 (9.0–14.7)

NS

apoCIIIHDL (mg/dl)

4.55 (3.32–6.68)

5.01 (3.81–7.44)

3.86 (3.07–6.15)

0.048

apoCIIIHDL ratio

0.43 (0.30–0.53)

0.48 (0.31–0.55)

0.37 (0.24–0.47)

0.003

  1. Data are expressed as mean ± SD or median (interquartile range). ANGPTL8 indicates angiopoietin-like protein 8; apoCIII, apolipoprotein CIII; apoCIIIHDL, apolipoprotein CIII in apoB-depleted plasma; apoCIIIHDL ratio, apolipoprotein CIII in apoB-depleted plasma over plasma apolipoprotein CIII; CAD, coronary artery disease